Zota Health Care, a company in the Pharmaceuticals industry, reported revenue of ₹199 crore and a net loss of ₹26 crore for the September 2026 quarter.
Zota Health Care (NSE: ZOTA) closed at ₹1,288.00 on 20 Nov 2026, down 22.9% over the past year. Its market capitalisation is ₹4,461 crore.
Zota Health Care Limited is a renowned pharmaceutical company that manufactures, markets, and exports pharmaceutical, ayurvedic, nutraceutical, and over-the-counter (OTC) products across boundaries into the semi-regulated and regulated markets of Asian Countries markets of African Countries, Russian Countries & Latin America.
Descriptive research only, not investment advice. Evenstocks is not a SEBI-registered investment adviser.